Results 341 to 350 of about 2,058,358 (352)

Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review

European Journal of Heart Failure, 2016
Arno W Hoes, Frans H Rutten
exaly  

Heart failure: preventing disease and death worldwide

ESC Heart Failure, 2014
Bambang Budi Siswanto, Gerasimos Filippatos, Hiroaki Shimokawa   +2 more
exaly  

Survival of patients with chronic heart failure in the community: a systematic review and meta‐analysis

European Journal of Heart Failure, 2019
Andrea K Roalfe, Clare J Taylor, F D Richard Hobbs   +2 more
exaly  

A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)

European Journal of Heart Failure, 2019
John Jv Mcmurray, David L Demets, Silvio E Inzucchi   +2 more
exaly  

Drug discovery for heart failure: a new era or the end of the pipeline?

Nature Reviews Drug Discovery, 2007
David M Kaye
exaly  

Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology

European Journal of Heart Failure, 2019
Rudolf A De Boer, Gilles W De Keulenaer, Johann Bauersachs   +2 more
exaly  

Treating oxidative stress in heart failure: past, present and future

European Journal of Heart Failure, 2019
Atze Van Der Pol, Wiek H Van Gilst, Adriaan A Voors   +2 more
exaly  

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

European Journal of Heart Failure, 2001
John Jv Mcmurray, Kate Macintyre, Simon Stewart   +2 more
exaly  

Contemporary results of anatomic radical prostatectomy

Ca-A Cancer Journal for Clinicians, 1999
exaly  

Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

European Journal of Heart Failure, 2019
Milton Packer, Javed Butler, Gerasimos Filippatos   +2 more
exaly